Trial Profile

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Azilsartan (Primary)
Indications Carotid stenosis; Essential hypertension
Focus Therapeutic Use
Acronyms ALIVE
Sponsors Takeda

Most Recent Events

20 May 2016 Status changed from recruiting to discontinued.
29 Feb 2016 Planned End Date changed from 1 Nov 2016 to 1 Jul 2017, according to ClinicalTrials.gov record.
29 Feb 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jul 2017, according to ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com